BioMarin Pharmaceutical Inc.: What Is Their Expected Revenue Growth After Ther Efforts Towards Streamlining Expenditure?

BioMarin Pharmaceutical Inc. reported strong financial results for Q1 2024, while implementing significant advances as part of the company’s new corporate vision and strategy. According to the firm, this is done in the interest of positively influencing patients’ lives and generating value for shareholders, with several strategic initiatives currently underway. Based on the company’s R&D portfolio assessment, three assets were chosen to be accelerated based on their potential to transform patients and shareholder value. However, the development of four programs that did not meet the new higher standard was discontinued.